Advanced Oncotherapy (AVO) wins Best Technology Award at the AIM Awards 2015

Advanced Oncotherapy (AVO) wins Best Technology Award at the AIM Awards 2015. Sponsored by | Sanlam Securities UK Picture shows, left to right: David Snell, Partner and AIM Leader, PwC; David Worlidge, Director, Corporate Finance, Sanlam Securities UK; Robert Rose, Operations and Manufacturing Director, Advanced Oncotherapy plc and Graham Pughe, Chief Accounting Officer and Vice […]